Penetrium Bioscience

187660 · KOSDAQ · Health Care · SMALL CAP

Rights offering: final issue price set

Penetrium Bioscience set the final issue price for its 8,500,000-share rights offering at US$2.16 per share (versus a round-1 price of US$2.84 and round-2 price of US$2.16), with a par value of US$0.07, as determined on 2026-07-31.

Capital raise(Rights offering: final issue price set)· FILED 2026-08-03· RCEPT 20260803900782

What happened

Rights offering: final issue price set

1. Planned issuance details a. Share Type: Registered common stock b. Number of Shares: 8,500,000

2. Final issue price (per share) a. Final Price (KRW): 3,085 b. Round-1 Issue Price (KRW): 4,050 c. Round-2 Issue Price (KRW): 3,085

3. Par Value (KRW): 100 4. Determination Date: 2026-07-31

5. Other matters for investment reference The issue price is set pursuant to Article 5-18 (Determination of issue price for rights offerings) of the Regulation on Issuance and Disclosure of Securities. Although the discount rate and other terms for a shareholder-allotment capital increase may now be freely determined, the company calculates the price by partially applying, by analogy, Article 57 of the former Regulation on Issuance and Disclosure of Securities, out of concern for market disruption and in line with existing practice.

(1) Calculation of the round-1 issue price: The reference price is the lower of (i) the arithmetic mean of the one-month weighted average price, one-week weighted average price, and the base-date weighted average price of the issuer's shares traded on the KOSDAQ market, calculated retroactively from the third trading day before the new-share allotment record date, and (ii) the base-date weighted average price; a 25% discount rate is applied under the formula below. If the resulting price is below par value, the par value is used as the issue price. (Amounts below the quotation unit are rounded up to the nearest quotation unit.) Round-1 issue price = [Reference price x (1 - discount rate)] / [1 + (rights-offering ratio x discount rate)]

(2) Round-2 issue price: The reference price is the lower of (i) the arithmetic mean of the one-week weighted average price and the base-date weighted average price of the issuer's shares traded on the KOSDAQ market, calculated retroactively from the third trading day before the existing shareholders' subscription date, and (ii) the base-date weighted average price; the price is determined using the formula below with a 25% discount rate applied. If the resulting offering price is at or below par value, the par value is used as the issue price. (Amounts below the quotation unit are rounded up to the nearest quotation unit.) Round-2 issue price = Reference price x (1 - discount rate)

(3) Final issue price: The lower of the round-1 and round-2 issue prices. However, pursuant to Article 165-6 of the Financial Investment Services and Capital Markets Act and Article 5-15-2 of the Regulation on Issuance and Disclosure of Securities, if the lower of the round-1 and round-2 issue prices is lower than the price calculated by applying a 40% discount rate to the weighted average price from the third to the fifth trading day before the subscription date, the final issue price is set as the price calculated by applying a 40% discount rate to that weighted average price. (Amounts below the quotation unit are rounded up to the nearest quotation unit.)

Related disclosures 2026-06-11: Resolution on rights offering (shareholder allotment with public offering of forfeited shares) 2026-04-30: Resolution on rights offering (shareholder allotment with public offering of forfeited shares) 2026-04-30: Securities registration statement (equity securities) 2026-05-27: Resolution on rights offering (shareholder allotment with public offering of forfeited shares) 2026-05-27: Securities registration statement (equity securities) 2026-06-11: Securities registration statement (equity securities) 2026-06-26: Resolution on rights offering (shareholder allotment with public offering of forfeited shares) 2026-06-26: Rights offering: round-1 issue price set 2026-06-26: Securities registration statement (equity securities) 2026-06-26: Prospectus 2026-06-26: Ex-rights (rights offering)

Filed2026-08-03, Rights offering: final issue price set
SourceDART rcept 20260803900782 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-08-03 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).